129 related articles for article (PubMed ID: 20183271)
21. Protection against beta-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice.
Yan JJ; Kim DH; Moon YS; Jung JS; Ahn EM; Baek NI; Song DK
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):25-30. PubMed ID: 14687853
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective potential of ethanolic extract of Pseudarthria viscida (L) Wight and Arn against beta-amyloid(25-35)-induced amnesia in mice.
Singh JC; Alagarsamy V; Parthiban P; Selvakumar P; Reddy YN
Indian J Biochem Biophys; 2011 Jun; 48(3):197-201. PubMed ID: 21793312
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of astragalosides on dexamethasone and Aβ25-35 induced learning and memory impairments due to decrease amyloid precursor protein expression in 12-month male rats.
Li WZ; Wu WY; Huang DK; Yin YY; Kan HW; Wang X; Yao YY; Li WP
Food Chem Toxicol; 2012 Jun; 50(6):1883-90. PubMed ID: 22484447
[TBL] [Abstract][Full Text] [Related]
24. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
[TBL] [Abstract][Full Text] [Related]
25. Abeta(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins.
Tohda C; Matsumoto N; Zou K; Meselhy MR; Komatsu K
Neuropsychopharmacology; 2004 May; 29(5):860-8. PubMed ID: 15010693
[TBL] [Abstract][Full Text] [Related]
26. Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.
Wang XH; Li L; Hölscher C; Pan YF; Chen XR; Qi JS
Neuroscience; 2010 Nov; 170(4):1239-48. PubMed ID: 20727946
[TBL] [Abstract][Full Text] [Related]
27. Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment.
Tota S; Kamat PK; Shukla R; Nath C
Behav Brain Res; 2011 Aug; 221(1):207-15. PubMed ID: 21382422
[TBL] [Abstract][Full Text] [Related]
28. Protective effect of N-acetyl-L-cysteine on amyloid beta-peptide-induced learning and memory deficits in mice.
Fu AL; Dong ZH; Sun MJ
Brain Res; 2006 Sep; 1109(1):201-6. PubMed ID: 16872586
[TBL] [Abstract][Full Text] [Related]
29. Loganin improves learning and memory impairments induced by scopolamine in mice.
Kwon SH; Kim HC; Lee SY; Jang CG
Eur J Pharmacol; 2009 Oct; 619(1-3):44-9. PubMed ID: 19666019
[TBL] [Abstract][Full Text] [Related]
30. Neurochemical and behavioral effects of the intrahippocampal co-injection of beta-amyloid protein1-40 and ibotenic acid in rats.
Li Y; Qin HQ; Chen QS; Wang JJ
Life Sci; 2005 Jan; 76(11):1189-97. PubMed ID: 15642590
[TBL] [Abstract][Full Text] [Related]
31. A novel cyclic squamosamide analogue compound FLZ improves memory impairment in artificial senescence mice induced by chronic injection of D-galactose and NaNO2.
Fang F; Liu G
Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):447-54. PubMed ID: 17971066
[TBL] [Abstract][Full Text] [Related]
32. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
Olcese JM; Cao C; Mori T; Mamcarz MB; Maxwell A; Runfeldt MJ; Wang L; Zhang C; Lin X; Zhang G; Arendash GW
J Pineal Res; 2009 Aug; 47(1):82-96. PubMed ID: 19538338
[TBL] [Abstract][Full Text] [Related]
33. Diphenyl diselenide improves scopolamine-induced memory impairment in mice.
Souza AC; Brüning CA; Leite MR; Zeni G; Nogueira CW
Behav Pharmacol; 2010 Sep; 21(5-6):556-62. PubMed ID: 20520530
[TBL] [Abstract][Full Text] [Related]
34. Jujuboside A, a neuroprotective agent from semen Ziziphi Spinosae ameliorates behavioral disorders of the dementia mouse model induced by Aβ 1-42.
Liu Z; Zhao X; Liu B; Liu AJ; Li H; Mao X; Wu B; Bi KS; Jia Y
Eur J Pharmacol; 2014 Sep; 738():206-13. PubMed ID: 24886882
[TBL] [Abstract][Full Text] [Related]
35. Timosaponin AIII, a saponin isolated from Anemarrhena asphodeloides, ameliorates learning and memory deficits in mice.
Lee B; Jung K; Kim DH
Pharmacol Biochem Behav; 2009 Aug; 93(2):121-7. PubMed ID: 19426756
[TBL] [Abstract][Full Text] [Related]
36. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
[TBL] [Abstract][Full Text] [Related]
37. ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice.
Kang SY; Lee KY; Koo KA; Yoon JS; Lim SW; Kim YC; Sung SH
Life Sci; 2005 Feb; 76(15):1691-705. PubMed ID: 15698848
[TBL] [Abstract][Full Text] [Related]
38. Lurasidone reverses MK-801-induced impairment of learning and memory in the Morris water maze and radial-arm maze tests in rats.
Enomoto T; Ishibashi T; Tokuda K; Ishiyama T; Toma S; Ito A
Behav Brain Res; 2008 Jan; 186(2):197-207. PubMed ID: 17881065
[TBL] [Abstract][Full Text] [Related]
39. Voluntary exercise counteracts Aβ25-35-induced memory impairment in mice.
Wang Q; Xu Z; Tang J; Sun J; Gao J; Wu T; Xiao M
Behav Brain Res; 2013 Nov; 256():618-25. PubMed ID: 24055357
[TBL] [Abstract][Full Text] [Related]
40. 5-Hydroxymethylfurfural, an antioxidant agent from Alpinia oxyphylla Miq. improves cognitive impairment in Aβ 1-42 mouse model of Alzheimer's disease.
Liu A; Zhao X; Li H; Liu Z; Liu B; Mao X; Guo L; Bi K; Jia Y
Int Immunopharmacol; 2014 Dec; 23(2):719-25. PubMed ID: 25445965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
